109 research outputs found

    The atrial natriuretic peptide (ANP) knockout mouse does not exhibit the phenotypic features of pre-eclampsia or demonstrate fetal growth restriction

    Get PDF
    The ANP knockout mouse is reported to exhibit pregnancy-associated hypertension, proteinuria and impaired placental trophoblast invasion and spiral artery remodeling, key features of pre-eclampsia (PE). We hypothesized that these mice may provide a relevant model of human PE with associated fetal growth restriction (FGR). Here, we investigated pregnancies of ANP wild type (ANP+/+), heterozygous (ANP+/-) and knockout (ANP−/-) mice. Maternal blood pressure did not differ between genotypes (E12.5, E17.5), and fetal weight (E18.5) was unaffected. Placental weight was greater in ANP−/− versus ANP+/+ mice. Therefore, in our hands, the ANP model does not express phenotypic features of PE with FGR

    Epizootic of beak deformities in wild birds: a review of avian keratin disorder worldwide

    Get PDF
    An epizootic of debilitating beak deformities in wild birds has been documented in recent decades. Avian keratin disorder (AKD) is characterized by overgrowth of beak keratin and was first observed in clusters among Black-capped Chickadees (Poecile atricapillus) in Alaska. The prevalence of beak deformities is higher among Black-capped Chickadees and American Crows (Corvus brachyrhynchos) in Alaska than in any other population ever recorded. Reports of birds with similar beak deformities have also been documented across North America, in South America, and in Europe. We compiled reports from community-science programs, bird monitoring studies, and scientific literature to summarize the current geographic scope and bird species affected by AKD-like beak deformities. From 1946 to 2021, >3,300 community-science observers reported 290 species with beak deformities, comprising >4,000 birds in Alaska, 1,900 elsewhere in North America, and >1,700 from outside of North America. We also examined the occurrence of beak deformities in populations of Red-tailed Hawks (Buteo jamaicensis) in the Pacific Northwest, Red-cockaded Woodpeckers (Dryobates borealis) in North Carolina, and Austral Thrushes (Turdus falcklandii) in Patagonia. Clinical signs of AKD in Black-capped Chickadees have been strongly associated with the occurrence of a novel picornavirus, which has now been detected in multiple species exhibiting morphologically similar beak deformities. Our detailed compilation, including geographic occurrence of individuals and species apparently affected, will help identify research and conservation actions required to evaluate and mitigate impacts of beak deformities on wild birds.Fil: Gerik, Daniel. United States Geological Survey; Estados UnidosFil: Van Hemert, Caroline. United States Geological Survey; Estados UnidosFil: Handel, Collen. United States Geological Survey; Estados UnidosFil: Lawson, Becki. Zoological Society of London. Institute of Zoology; Reino UnidoFil: Walters, Jeff. Virginia Tech University; Estados UnidosFil: Brust, Kerry. Sandhills Ecological Institute; Estados UnidosFil: Prinz, Anna. Sandhills Ecological Institute; Estados UnidosFil: Van Lanen, Andy. Sandhills Ecological Institute; Estados UnidosFil: Schillaci, Jessie. Directorate of Public Works; Estados UnidosFil: Cottrell, Susan. Falcon Research Group; Estados UnidosFil: Anderson, Clifford. Falcon Research Group; Estados UnidosFil: Gorosito, Cristian Andrés. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Patagonia Norte. Centro de Investigación Esquel de Montaña y Estepa Patagónica. Universidad Nacional de la Patagonia "San Juan Bosco". Centro de Investigación Esquel de Montaña y Estepa Patagónica; ArgentinaFil: Cueto, Víctor. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Patagonia Norte. Centro de Investigación Esquel de Montaña y Estepa Patagónica. Universidad Nacional de la Patagonia "San Juan Bosco". Centro de Investigación Esquel de Montaña y Estepa Patagónica; ArgentinaFil: Zylberberg, Maxine. University of California; Estados Unidos20th Alaska Bird ConferenceAnchorageEstados UnidosUS Fish and Wildlife Service's Migratory Bird Management Divisio

    A randomized phase 2 study of paclitaxel and carboplatin with or without conatumumab for first-line treatment of advanced non-small-cell lung cancer

    Get PDF
    Introduction: This study evaluated the efficacy, safety, and pharmacokinetics of conatumumab combined with paclitaxel-carboplatin (PC) as first-line treatment for advanced non-small-cell lung cancer (NSCLC). Methods: Patients (aged >18 years) with previously untreated advanced or recurrent NSCLC were randomized 1: 1: 1 (stratified by Eastern Cooperative Oncology Group performance status and disease stage) to receive up to six 3-week cycles of PC combined with conatumumab (arm 1, 3 mg/kg; arm 2, 15 mg/kg) or placebo (arm 3) every 3 weeks. The primary endpoint was progression-free survival (PFS). This study is registered with ClinicalTrials.gov (NCT00534027). Results: Between August 8, 2007 and April 9, 2009, 172 patients were randomized (arm 1, n = 57; arm 2, n = 56; arm 3, n = 59). Median PFS was 5.4 months (95% confidence interval [CI] 4.1-6.3) in arm 1 (hazard ratio [HR] 0.84 [95% CI 0.57-1.24]; p = 0.41), 4.8 months (95% CI 3.2-6.5) in arm 2 (HR 0.93 [0.64-1.35]; p = 0.57), and 5.5 months (95% CI 4.3-5.7) in arm 3. There was an interaction between tumor histology and the effect of conatumumab on PFS (squamous HR 0.47 [0.23-0.94]; nonsquamous HR 1.08 [0.74-1.57]; interaction p = 0.039). The most common grade of three or more adverse events were neutropenia, anemia, and thrombocytopenia. There was no evidence of pharmacokinetic interactions between conatumumab and PC. Of 158 patients assessable for FCGR3A polymorphisms, conatumumab treatment was associated with a trend toward longer overall survival (HR 0.72 [0.43-1.23]) among V-allele carriers (V/V or F/V; n = 54) but not among F-allele homozygotes (n = 34; HR 1.37 [0.66-2.86]). Conclusion: Although well tolerated, the addition of conatumumab to PC did not improve outcomes in unselected patients with previously untreated advanced NSCLC

    Clinical Study Individual-, Family-, Community-, and Policy-Level Impact of a School-Based Cardiovascular Risk Detection Screening Program for Children in Underserved, Rural Areas: The CARDIAC Project

    Get PDF
    The Coronary Artery Risk Detection In Appalachian Communities (CARDIAC) Project has screened more than 80,000 children (10-12 years) for cardiovascular and diabetes risk factors over the past 15 years. Simultaneous referral and intervention efforts have also contributed to the overall program impact. In this study, we examined evidence of programmatic impact in the past decade at the individual, family, community, and policy levels from child screening outcomes, referral rates, participation in subsequent services, and policies that embed the activities of the project as a significant element. Within this period of time, fifth-grade overweight and obesity rates were maintained at a time when rates elsewhere increased. 107 children were referred for additional screening and treatment for probable familial hypercholesterolemia (FH); 82 family members were subsequently screened in family-based screening efforts. 58 grants were distributed throughout the state for community-appropriate obesity intervention. A state wellness policy embedded CARDIAC as the method of assessment and national child cholesterol screening guidelines were impacted by CARDIAC findings. The sustainability and successful impact of this school-based program within a largely underserved, rural Appalachian state are also discussed

    Global database on large magnitude explosive volcanic eruptions (LaMEVE)

    Get PDF
    © 2012 Crosweller et al. To facilitate the assessment of hazards and risk from volcanoes, we have created a comprehensive global database of Quaternary Large Magnitude Explosive Volcanic Eruptions (LaMEVE). This forms part of the larger Volcanic Global Risk Identification and Analysis Project (VOGRIPA), and also forms part of the Global Volcano Model (GVM) initiative (www.globalvolcanomodel.org). A flexible search tool allows users to select data on a global, regional or local scale; the selected data can be downloaded into a spreadsheet. The database is publically available online at www.bgs.ac. uk/vogripa and currently contains information on nearly 3,000 volcanoes and over 1,800 Quaternary eruption records. Not all volcanoes currently have eruptions associated with them but have been included to allow for easy expansion of the database as more data are found. Data fields include: Magnitude, Volcanic Explosivity Index (VEI), deposit volumes, eruption dates, and rock type. The scientific community is invited to contribute new data and also alert the database manager to potentially incorrect data. Whilst the database currently focuses only on large magnitude eruptions, it will be expanded to include data specifically relating to the principal volcanic hazards (e.g. pyroclastic flows, tephra fall, lahars, debris avalanches, ballistics), as well as vulnerability (e.g. population figures, building type) to facilitate risk assessments of future eruptions

    Analgesia mediated by the TRPM8 cold receptor in chronic neuropathic pain

    Get PDF
    SummaryBackgroundChronic established pain, especially that following nerve injury, is difficult to treat and represents a largely unmet therapeutic need. New insights are urgently required, and we reasoned that endogenous processes such as cooling-induced analgesia may point the way to novel strategies for intervention. Molecular receptors for cooling have been identified in sensory nerves, and we demonstrate here how activation of one of these, TRPM8, produces profound, mechanistically novel analgesia in chronic pain states.ResultsWe show that activation of TRPM8 in a subpopulation of sensory afferents (by either cutaneous or intrathecal application of specific pharmacological agents or by modest cooling) elicits analgesia in neuropathic and other chronic pain models in rats, thereby inhibiting the characteristic sensitization of dorsal-horn neurons and behavioral-reflex facilitation. TRPM8 expression was increased in a subset of sensory neurons after nerve injury. The essential role of TRPM8 in suppression of sensitized pain responses was corroborated by specific knockdown of its expression after intrathecal application of an antisense oligonucleotide. We further show that the analgesic effect of TRPM8 activation is centrally mediated and relies on Group II/III metabotropic glutamate receptors (mGluRs), but not opioid receptors. We propose a scheme in which Group II/III mGluRs would respond to glutamate released from TRPM8-containing afferents to exert an inhibitory gate control over nociceptive inputs.ConclusionsTRPM8 and its central downstream mediators, as elements of endogenous-cooling-induced analgesia, represent a novel analgesic axis that can be exploited in chronic sensitized pain states
    • 

    corecore